September 22-23 – The "DIA China 2022 Forum on Patient Safety Science and Risk Management” was held in Shanghai. The first 2-day forum on patient safety science and risk management brought together the scientific community and stakeholders across disciplines to discuss the framework of safety science, RMP, ICSR processes, drug safety in different therapeutic areas and risk management. To share our extensive experience in pharmacovigilance services, Yang Qiang, Senior Director of Pharmacovigilance at Clin-nov Medical, presented on "Key Considerations for Individual Case Safety Reports in International Multicenter Studies".